ECM
EBS icon

EMC Capital Management’s Emergent Biosolutions EBS Stock Holding History

EMC Capital Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,965
Closed -$10K – 288
2023
Q4 		$10K Hold
3,965
– – 0.01% 271
2023
Q3 		$13K Buy
3,965
+1,818
+85% +$10.1K 0.01% 277
2023
Q2 		$397 Sell
2,147
-1,818
-46% -$16.9K 0.31% 41
2023
Q1 		$41K Hold
3,965
– – 0.03% 261
2022
Q4 		$47K Buy
3,965
+108
+3% +$1.67K 0.04% 260
2022
Q3 		$81K Hold
3,857
– – 0.08% 220
2022
Q2 		$120K Buy
3,857
+1,287
+50% +$43.9K 0.1% 209
2022
Q1 		$83K Buy
+2,570
New +$113K 0.06% 256

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

EMC Capital Management's EBS Position: Q1 2024 in Review

EMC Capital Management sold out of Emergent Biosolutions (EBS) in Q1 2024, closing a stake of 3,965 shares — an estimated $10K sold.

EMC Capital Management first reported a position in EBS in Q1 2022 and held it in 8 quarters. The position peaked at $120K in Q2 2022. 122 funds tracked by Wall St. Rank hold EBS as of Q1 2024.

  • EMC Capital Management reported no remaining Emergent Biosolutions position as of Q1 2024 after selling out during the quarter.
  • EMC Capital Management sold 3,965 Emergent Biosolutions shares in Q1 2024, an estimated $10K.
  • EMC Capital Management first reported a position in Emergent Biosolutions in Q1 2022 and held it in 8 quarters.
  • EMC Capital Management's Emergent Biosolutions position peaked at $120K in Q2 2022.
  • 122 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2024.

Based on EMC Capital Management's 13F filing for Q1 2024, filed 20 May 2024.